Alexium International Group Limited (E7T) - Net Assets
Based on the latest financial reports, Alexium International Group Limited (E7T) has net assets worth €-402.08K EUR (≈ $-470.07K USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€2.88 Million ≈ $3.36 Million USD) and total liabilities (€3.28 Million ≈ $3.83 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Alexium International Group Limited liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €-402.08K |
| % of Total Assets | -13.98% |
| Annual Growth Rate | N/A |
| 5-Year Change | -109.62% |
| 10-Year Change | -103.57% |
| Growth Volatility | 1299.5 |
Alexium International Group Limited - Net Assets Trend (2013–2025)
This chart illustrates how Alexium International Group Limited's net assets have evolved over time, based on quarterly financial data. Also explore Alexium International Group Limited balance sheet assets for the complete picture of this company's asset base.
Annual Net Assets for Alexium International Group Limited (2013–2025)
The table below shows the annual net assets of Alexium International Group Limited from 2013 to 2025. For live valuation and market cap data, see market cap of Alexium International Group Limited.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | €-402.08K ≈ $-470.07K |
-112.18% |
| 2024-06-30 | €3.30 Million ≈ $3.86 Million |
+435.89% |
| 2023-06-30 | €-983.14K ≈ $-1.15 Million |
-162.39% |
| 2022-06-30 | €1.58 Million ≈ $1.84 Million |
-62.29% |
| 2021-06-30 | €4.18 Million ≈ $4.88 Million |
-47.17% |
| 2020-06-30 | €7.91 Million ≈ $9.25 Million |
+1348.10% |
| 2019-06-30 | €546.12K ≈ $638.48K |
-94.22% |
| 2018-06-30 | €9.45 Million ≈ $11.05 Million |
+4206.08% |
| 2017-06-30 | €219.47K ≈ $256.59K |
-98.05% |
| 2016-06-30 | €11.27 Million ≈ $13.17 Million |
-4.57% |
| 2015-06-30 | €11.81 Million ≈ $13.80 Million |
+287.78% |
| 2014-06-30 | €3.04 Million ≈ $3.56 Million |
+1049.76% |
| 2013-06-30 | €-320.58K ≈ $-374.79K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Alexium International Group Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 7276517600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €72.36 Million | % |
| Total Equity | €-402.08K | 100.00% |
Alexium International Group Limited Competitors by Market Cap
The table below lists competitors of Alexium International Group Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Stayble Therapeutics AB
ST:STABL
|
$1.83 Million |
|
Labrador Technologies Inc
V:LTX
|
$1.83 Million |
|
PSYCHED WELLNESS LTD
F:5U9
|
$1.83 Million |
|
Monarca Minerals Inc
V:MMN
|
$1.83 Million |
|
Dotdigital Group Plc
LSE:DOTD
|
$1.82 Million |
|
NTR Holding A/S
CO:NTR-B
|
$1.82 Million |
|
PREMIA FINANCE O.N.
F:81U
|
$1.82 Million |
|
Northern Venture Trust
LSE:NVT
|
$1.82 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Alexium International Group Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 3,302,222 to -402,078, a change of -3,704,300 (-112.2%).
- Net loss of 3,926,289 reduced equity.
- Share repurchases of 6,401 reduced equity.
- Other factors increased equity by 228,390.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-3.93 Million | -976.5% |
| Share Repurchases | €6.40K | -1.59% |
| Other Changes | €228.39K | +56.8% |
| Total Change | €- | -112.18% |
Book Value vs Market Value Analysis
This analysis compares Alexium International Group Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-06-30 | €0.00 | €0.00 | x |
| 2018-06-30 | €0.02 | €0.00 | x |
| 2019-06-30 | €0.00 | €0.00 | x |
| 2020-06-30 | €0.01 | €0.00 | x |
| 2021-06-30 | €0.01 | €0.00 | x |
| 2022-06-30 | €0.00 | €0.00 | x |
| 2023-06-30 | €0.00 | €0.00 | x |
| 2024-06-30 | €0.00 | €0.00 | x |
| 2025-06-30 | €0.00 | €0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Alexium International Group Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -100.12%
- • Asset Turnover: 1.36x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-630.58%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 0.00% | -711.44% | 0.19x | 0.00x | €-2.35 Million |
| 2014 | -109.58% | -1376.09% | 0.05x | 1.67x | €-3.64 Million |
| 2015 | -99.63% | -19874.25% | 0.00x | 1.07x | €-12.94 Million |
| 2016 | -137.07% | -514.62% | 0.21x | 1.26x | €-16.57 Million |
| 2017 | -5538.36% | -51.05% | 2.47x | 43.97x | €-12.18 Million |
| 2018 | -56.71% | -33.25% | 0.77x | 2.22x | €-6.30 Million |
| 2019 | -1811.90% | -137.17% | 0.53x | 24.95x | €-9.95 Million |
| 2020 | -112.86% | -100.77% | 0.52x | 2.15x | €-9.72 Million |
| 2021 | -34.59% | -19.86% | 0.69x | 2.51x | €-1.86 Million |
| 2022 | -213.26% | -41.10% | 1.27x | 4.08x | €-3.52 Million |
| 2023 | 0.00% | -40.93% | 1.34x | 0.00x | €-2.85 Million |
| 2024 | -83.60% | -46.85% | 1.13x | 1.58x | €-3.09 Million |
| 2025 | 0.00% | -100.12% | 1.36x | 0.00x | €-3.89 Million |
Industry Comparison
This section compares Alexium International Group Limited's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $922,008,575
- Average return on equity (ROE) among peers: -47.83%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Alexium International Group Limited (E7T) | €-402.08K | 0.00% | N/A | $1.83 Million |
| LIFELINE SPAC I OYJ A EO1 (0CD) | $3.93 Million | 0.00% | 25.02x | $261.36 Million |
| GRAPHENE MANUFACT.GROUP (0GF) | $10.10 Million | -116.54% | 0.65x | $185.36 Million |
| Orion Engineered Carbons SA (0OE) | $459.40 Million | 23.12% | 3.11x | $327.05 Million |
| COVESTRO AG SP.ADR 1/2 (1CO1) | $7.76 Billion | 20.82% | 1.01x | $11.11 Billion |
| H&R GmbH & Co. KGaA (2HRA) | $346.88 Million | -2.60% | 1.15x | $183.88 Million |
| LOOP INDUSTRIES DL-001 (3L9) | $14.14 Million | -149.11% | 0.45x | $58.01 Million |
| Dotz Nano Ltd (57N) | $4.06 Million | -195.35% | 0.31x | $4.51 Million |
| TIDEWATER RENEWABLES LTD (7GZ) | $550.12 Million | 4.72% | 0.81x | $233.52 Million |
| DIRECTA PLUS PLC LS-0025 (88K) | $16.03 Million | -22.78% | 0.36x | $2.35 Million |
| TEKNA HOLDING ASA NK 2 (8VB) | $53.41 Million | -40.60% | 0.38x | $67.10 Million |
About Alexium International Group Limited
Alexium International Group Limited provides performance chemicals for advanced materials applications with a focus on flame retardancy and thermal management in the United States. It offers thermal regulation solutions, such as Alexicool, a PCM finishing treatment for fabrics; Biocool, a natural and biobased microencapsulated PCM cooling; Eclipsys, a perpetual cooling technology that enhance the… Read more